Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP) [Phase 2]
This update confirms the completion of a Phase 2 study evaluating AR-12286 in patients with elevated intraocular pressure. No efficacy resul…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing brinzolamide/brimonidine fixed combination given twice daily versus separate brinzolamide and brimonidine in open-an…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Safety and Efficacy of Combigan® Ophthalmic Solution in Korea
The document reports the completion of a Korea-based trial evaluating the safety and efficacy of Combigan ophthalmic solution for open-angle…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
This document reports the results of an observational study evaluating Lumigan 0.01% (bimatoprost) in patients with primary open-angle glauc…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days [Phase 2]
Phase 2 trial evaluating PG286 ophthalmic solution 0.5% versus its components over 28 days in open-angle glaucoma and ocular hypertension ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial compared a fixed-dose combination of brinzolamide 1% and timolol 0.5% with separate brinzolamide 1% plus timolol 0.5% in ope…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
This document reports the completion of a Phase 1/Phase 2 safety and efficacy study of OPA-6566 Ophthalmic Solution in subjects with primary…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 study comparing brinzolamide/brimonidine fixed-dose combination given twice daily to its individual components in open-angle glaucom…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) [Phase 4]
A Phase 4 safety and efficacy study evaluating bimatoprost 0.01% in primary open-angle glaucoma or ocular hypertension; results were posted …
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG [Phase 2]
This update reports the completion of a Phase 2 study evaluating L-PPDS with adjunctive Xalatan eye drops in individuals with ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Efficacy of Changing to DUOTRAV® From Prior Therapy [Phase 4]
Phase 4 trial assessing switching to DuoTrav from prior therapy in open-angle glaucoma, ocular hypertension, and pigment dispersion glaucoma…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Patient Preference Comparison of AZARGA Versus COSOPT [Phase 4]
Phase 4 trial comparing patient preference between AZARGA and COSOPT in open-angle glaucoma and ocular hypertension; results were completed …
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Neurovascular Coupling in Eyes of Glaucoma Patients
This clinical trial update reports the completion of a study on neurovascular coupling in the eyes of glaucoma patients, including individua…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension [Phase 4]
Phase 4 trial assessing safety and efficacy of ALPHAGAN P and LUMIGAN in patients previously treated with latanoprost for glaucoma and ocula…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension [Phase 1, Phase 2]
Phase 1/2 studies evaluating the safety and efficacy of liposomal latanoprost for ocular hypertension have completed.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]
Phase 2 study comparing AGN-210669 ophthalmic solution with bimatoprost ophthalmic solution in open-angle glaucoma or ocular hypertension; r…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Ocular Hypertension Treatment Study (OHTS)
Clinical trial update indicating the Ocular Hypertension Treatment Study (OHTS) has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C [Phase 2]
A Phase 2 trial evaluating AL-59412C in open-angle glaucoma and ocular hypertension reported safety data and intraocular pressure-lowering e…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Travoprost 3-Month Safety and Efficacy Study [Phase 3]
Phase 3 trial evaluating Travoprost for safety and efficacy in open-angle glaucoma and ocular hypertension has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1, Phase 2]
This clinical trial update reports on the safety and efficacy of AGN 210669 Ophthalmic Solution in patients with ocular hypertension or prim…
-
CLINICAL_TRIALS trial_result · 2013-10-18Clinical Trial Update: Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution [Phase 2]
A Phase 2 trial comparing three formulations of AGN-210669 ophthalmic solution against Bimatoprost ophthalmic solution for glaucoma (open-an…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
This document reports the completion of a Phase 2 dose-evaluation study of the latanoprost punctal plug delivery system (L-PPDS) in subjects…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma [Phase 2]
Phase 2 dose-evaluation trial assessing the effect of punctal plug placement on the efficacy and safety of the Latanoprost punctal plug deli…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: A Study of LUMIGAN® RC in the Clinical Setting [Phase 4]
Phase 4 clinical trial update for LUMIGAN RC in glaucoma and ocular hypertension; the study has completed and results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
This clinical trial update reports the completion and posting of results for an observational study evaluating Lumigan (bimatoprost) 0.01% f…